New graft aims to make dialysis safer for kidney patients

NCT ID NCT04671771

Recruiting now Disease control Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the InnAVasc graft, which is surgically placed in the arm to provide a reliable access point for hemodialysis in people with end-stage kidney disease. About 133 participants will receive the graft and be followed for two years to see how well it works and how safe it is. The main goals are to keep the graft functioning at 6 months and to track any serious side effects like infection or bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: InnAVasc Arteriovenous Graft (a surgical implant for dialysis access)
What this could lead to: If successful, this graft could provide a safer, more reliable option for dialysis access in people with kidney failure, reducing complications like infection or bleeding.
What could go wrong: This is a mid-stage study with 133 participants, so results may not apply to everyone. The graft could still fail or cause serious side effects like infection or blockage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC RENAL DISEASE END STAGE RENAL DISEASE (ESRD) HEMODIALYSIS KIDNEY FAILURE

Contacts and locations

Locations

AKDHC Medical Research Services, LLC
RECRUITING

Phoenix, Arizona, 85012, United States
Baylor Heart and Vascular
NOT_YET_RECRUITING

Dallas, Texas, 75246, United States
Brigham & Women's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Duke University Medical Center
RECRUITING

Durham, North Carolina, 27705, United States
Guthrie Clinic
RECRUITING

Sayre, Pennsylvania, 18840, United States
Houston Methodist Hopsital
RECRUITING

Houston, Texas, 77030, United States
Medical University of South Carolina
RECRUITING

Orangeburg, South Carolina, 29118, United States
Montefiore Medical Center
RECRUITING

The Bronx, New York, 10467, United States
Mount Sinai Hospital
RECRUITING

New York, New York, 10029, United States
NC Heart and Vascular Research, LLC
ACTIVE_NOT_RECRUITING

Raleigh, North Carolina, 27607, United States
Northwell Health
RECRUITING

New York, New York, 10075, United States
Piedmont Augusta
RECRUITING

Augusta, Georgia, 30901, United States
Prisma Health- Upstate
RECRUITING

Greenville, South Carolina, 29615, United States
Rutgers
RECRUITING

Newark, New Jersey, 07103, United States
Sarasota Memorial Hospital
RECRUITING

Sarasota, Florida, 34239, United States
Surgical Specialists of Charlotte
RECRUITING

Charlotte, North Carolina, 28204, United States
University of Louisville
RECRUITING

Louisville, Kentucky, 40202, United States
University of Maryland
RECRUITING

Baltimore, Maryland, 21201, United States
University of South Florida
RECRUITING

Tampa, Florida, 33606, United States
University of Washington
RECRUITING

Seattle, Washington, 98195, United States
WakeMed
RECRUITING

Raleigh, North Carolina, 27610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.